NCT03650010 Total Ankle Replacement: Clinical and Radiological Outcomes
| NCT ID | NCT03650010 |
| Status | Recruiting |
| Phase | — |
| Sponsor | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
| Condition | Ankle Arthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,066 participants |
| Start Date | 2016-05-11 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,066 participants in total. It began in 2016-05-11 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This retrospective and prospective study intends to evaluate the epidemiology and effectiveness of ankle joint surgery in patients operated from January 2011 to March 2026, evaluating the results both clinically and radiographically.
Eligibility Criteria
Inclusion Criteria: * Males and females * age ≥ 18 years at the time of surgery * patients who underwent ankle replacement surgery from January 2011 to March 2026 Exclusion Criteria: \- age \< 18 years at the time of surgery
Frequently Asked Questions
Who can join the NCT03650010 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ankle Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03650010 currently recruiting?
Yes, NCT03650010 is actively recruiting participants. Visit ClinicalTrials.gov or contact I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio to inquire about joining.
Where is the NCT03650010 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT03650010 clinical trial?
NCT03650010 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. The trial plans to enroll 1,066 participants.